These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 8442431

  • 1. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J.
    J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
    [Abstract] [Full Text] [Related]

  • 2. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
    Ureña P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS, Souberbielle JC, Segre GV, Drüeke TB, De Vernejoul MC.
    J Bone Miner Res; 1995 Jun 15; 10(6):932-9. PubMed ID: 7572317
    [Abstract] [Full Text] [Related]

  • 6. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics.
    Charles P, Mosekilde L, Risteli L, Risteli J, Eriksen EF.
    Bone Miner; 1994 Feb 15; 24(2):81-94. PubMed ID: 8199535
    [Abstract] [Full Text] [Related]

  • 7. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y, Ochi M, Tokue A.
    Hinyokika Kiyo; 2000 Dec 15; 46(12):869-72. PubMed ID: 11211802
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 15; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 10. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
    Tähtelä R, Thölix E.
    Anticancer Res; 1996 Mar 15; 16(4B):2289-93. PubMed ID: 8694558
    [Abstract] [Full Text] [Related]

  • 11. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
    de Boer H, Blok GJ, Popp-Snijders C, Sips A, Lips P, van der Veen E.
    J Bone Miner Res; 1998 Feb 15; 13(2):245-52. PubMed ID: 9495517
    [Abstract] [Full Text] [Related]

  • 12. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.
    Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gärdsell P, Obrant KJ.
    J Bone Miner Res; 1995 Nov 15; 10(11):1823-9. PubMed ID: 8592961
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
    Tanaka K, Shiraishi K, Sakamoto A, Jojima H, Masuchi K, Okubo Y, Tanaka M, Fuzimatsu Y, Fukahori S, Osabe S, Imamura Y, Honda J, Oizumi K.
    Rinsho Ketsueki; 1998 Apr 15; 39(4):273-80. PubMed ID: 9597894
    [Abstract] [Full Text] [Related]

  • 14. Type I collagen and procollagen fragments in patients with metabolic bone diseases.
    Lin JS, Kao JT, Tsai KS.
    J Formos Med Assoc; 1996 Jul 15; 95(7):523-9. PubMed ID: 8840753
    [Abstract] [Full Text] [Related]

  • 15. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.
    Lieuw-A-Fa M, Sierra RI, Specker BL.
    J Bone Miner Res; 1995 Jun 15; 10(6):849-53. PubMed ID: 7572307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar 15; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

  • 19. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.
    J Rheumatol; 1998 Dec 15; 25(12):2339-44. PubMed ID: 9858427
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.